In this regard, HS20 may be useful for multiple tumor types by targeting different glypicans, such as GPC1 in pancreatic cancer [42,43], GPC2 in pre-B cell ALL [44], and GPC5 in rhabdomyosarcoma [45,46]. Here, GPC1 is linked to familial pancreatic carcinoma.